![Ypso-Facto invests an additional €1M in the development of software for the design and evaluation of chemical and biotechnological processes](https://ala.associates/wp-content/uploads/2022/04/RM-Nicoud-e1533285924634-500x250-1.jpg)
![Ypso-Facto invests an additional €1M in the development of software for the design and evaluation of chemical and biotechnological processes](https://ala.associates/wp-content/uploads/2022/04/RM-Nicoud-e1533285924634-500x250-1.jpg)
![Kyomed becomes KYomed INNOV](https://ala.associates/wp-content/uploads/2022/04/P1040078-500x250-1.jpg)
Kyomed becomes KYomed INNOV
![Sofradir and ULIS undergo structural reorganization to improve efficiency](https://ala.associates/wp-content/uploads/2022/04/Plaque-Slicium-avec-operateur-1-500x250-1.jpg)
Sofradir and ULIS undergo structural reorganization to improve efficiency
![Genopole a attiré plus de 100 chercheurs et chercheuses depuis 20 ans](https://ala.associates/wp-content/uploads/2022/04/Dynamiser-la-recherche-500x250-1.jpg)
Genopole a attiré plus de 100 chercheurs et chercheuses depuis 20 ans
![ULIS sets new performance record for bolometers; now match speeds of high frame-rate cameras](https://ala.associates/wp-content/uploads/2018/04/ULIS-breaking-FoM-record_09-04-18.png)
ULIS sets new performance record for bolometers; now match speeds of high frame-rate cameras
![Domain’s business model gains validation through Prexton’s acquisition by Lundbeck for up to $1.1 billion](https://ala.associates/wp-content/uploads/2018/03/Pascal-NEUVILLE_DOMAIN-Therapeutics_portrait-895x675.png)
Domain’s business model gains validation through Prexton’s acquisition by Lundbeck for up to $1.1 billion
![Lundbeck to acquire Prexton Therapeutics in a deal valued at up to €905 million](https://ala.associates/wp-content/uploads/2017/02/CONQUET-Francois-e1486458395645-1080x675.jpg)
Lundbeck to acquire Prexton Therapeutics in a deal valued at up to €905 million
![Minafin invests €14.5M ($18M) to extend Minakem’s production capacity in France](https://ala.associates/wp-content/uploads/2018/03/Phototheque-Dunkerque-8427-1080x675.jpg)
Minafin invests €14.5M ($18M) to extend Minakem’s production capacity in France
![Citoxlab acquires Solvo Biotechnology, the leading CRO specializing in drug transporter research and Drug-Drug Interactions](https://ala.associates/wp-content/uploads/2018/03/Citoxlab-Solvo.png)
Citoxlab acquires Solvo Biotechnology, the leading CRO specializing in drug transporter research and Drug-Drug Interactions
![Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics](https://ala.associates/wp-content/uploads/2017/02/Photo-Marc-Martinell-2015-1080x675.jpg)